C, Bianchi-Fior P, Cormier B. Cardiac manifestations of rheumatoid arthritis: a case-control transesophageal echocardiography study in 30 patients. Arthritis Care Res. 2001;45:129–35.
7. Corrao S, Salli L, Arnone S. Cardiac involvement in rheumatoid arthritis: evidence of silent heart disease. Eur Heart J. 1995;16:253–6.
8. Perera A, Fertig N, Lucas M. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. Arthritis Rheum. 2007;56:2740–46.
9. Meune C, Avouac J, Wahbi K. Cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography during routine care: a controlled study of 100 consecutive patients. Arthritis Rheum. 2008;58:1803–9.
10. Quayiumi S, Hassan ZU, Toone E. Seronegative spondiloarthropathies in lone aortic insufficiency. Arch Intern Med. 1985;145: 822–4.
11. Roldan CA, Chavez J, Wiest PW. Aortic root disease and valve disease associated with ankylosing spondylitis. J Am Coll Cardiol. 1998;32:1397–1404.
12. Kornbluth M, Schnittger I, Eyngorina I. Clinical outcome in the Marfan syndrome with ascending aortic dilatation followed annually by echocardiography. Am J Cardiol. 1999;84:753–5.
13. Rybczynski M, Treede H, Sheikhzadeh S. Predictors of outcome of mitral valve prolapse in the Marfan Syndrome. Am J Cardiol. 2011;107:268–74.
14. De Backer J, Loeys B, Devos D. A critical analysis of minor cardiovascular criteria in the diagnostic evaluation of patients with Marfan syndrome. Genet Med. 2006;8:401–8.
15. Watanabe S, Ishimitsu T, Inoue K. Type IV Ehlers-Danlos syndrome associated with mitral valve prolapse: a case report. J Cardiol Suppl. 1988;18:97–105.
16. Bonita RE, Choen IS, Berko BA. Valvular heart disease in osteogenesis imperfecta: presentation of a case and review of the literature. Echocardiography. 2010;27:69–73.
17. Hirata K, Kakazu M, Wake M. Acute aortic valvular regurgitation secondary to avulsion of aortic valve commissure in a patient with pseudoxanthoma elasticum. Intern Med. 2000;39:940–2.
18. Grimaldi A, Alfieri O, Camici PG. “African sickness” and the heart: the mystery of endomyocardial fibrosis [in Italian]. G Ital Cardiol (Rome). 2011;12:484–91.
19. Lacoste C, Mansencal N, Ben M’rad M. Valvular involvement in ANCA-associated systemic vasculitis: a case report and literature review. BMC Musculoskelet Disord. 2011;12: 50-9.
20. Mishell JM. Cases from the Osler Medical Service at Johns Hopkins University: cardiac valvular lesions in Wegener’s granulamatosis. Am J Med. 2002;113:607–9.
21. Tsui KL, Lee KW, Chan WK. Behcet’s aortitis and aortic regurgitation: a report of two cases. J Am Soc Echocardiogr. 2004;17:83–6.
22. Gunal N, Kara N, Cakar N. Cardiac involvement in childhood polyarteritis nodosa. Int J Cardiol. 1997;60:257–62.
23. Kerr GS, Hallahan CW, Giordano J. Takayasu arteritis. Ann Intern Med. 1994;120:919–29.
24. Soto ME, Espinola-Zavaleta N, Ramirez-Quito O. Echocardiographic follow-up of patients with Takayasu’s arteritis: five-year survival. Echocardiography. 2006;23:353–60.
25. Connolly HM, Schaff HV, Mullany CJ. Surgical management of left-sided carcinoid heart disease. Circulation. 2001;104(12 suppl 1):I36–40.
26. Pandya UH, Pellikka PA, Enriquez-Sarano M. Metastatic carcinoid tumor to the heart: echocardiographic-pathologic study of 11 patients. J Am Coll Cardiol. 2002;40:1328–32.
27. Lopez JA, Ross RS, Fishbein MC. Nonbacterial thrombotic endocarditis: a review. Am Heart J. 1987;113:773–4.
28. ishi H, Mitsuno M, Ryomoto M. Severe mitral regurgitation due to cardiac amyloidosis—a rare reason for ruptured chordate. Interact Cardiovasc Thorac Surg. 2008;7:1199–200.
29. Nelson JE, Kirschner PA, Teirstein AS. Sarcoidosis presenting as heart disease. Sarcoidosis Vasc Diffuse Lung Dis. 1996;13: 178–182.
30. Schieken RM, Kerber RE, Ionasescu VV. Cardiac manifestations of mucopolysaccharidoses. Circulation. 1975;52:700–5.
31. Butman SM, Karl L, Copeland JG. Combined aortic and mitral valve replacement in an adult with Scheie’s disease. Chest. 1989;96:209–10.
32. Desnick RJ, Blieden LC, Sharp HL. Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies. Circulation. 1976;54:818–25.
33. Grimaldi A, Vermi AC, Alfieri O. Calcified left ventricular endomyocardial fibrosis. J Heart Valve Dis. 2012;21:384–386.
34. Mocumbi AO, Ferreira MB, Sidi D. A population study of endomyocardial fibrosis in a rural area of Mozambique. N Engl J Med. 2008;359:43–9.
35. Linefsky JP, O’Brien KD, Katz R. Association of serum phosphate levels with aortic valve sclerosis and annular calcification the cardiovascular health study. J Am Coll Cardiol. 2011;58:291–7.
36. Walker MD, Fleischer JB, Di Tullio MR. Cardiac structure and diastolic function in mild primary hyperparathyroidism. Clin Endocrinol Metab. 2010;95:2172–9.
37. Stritzke J, Linsel-Nitschke P, Markus MRP; MONICA/ KORA Investigators. Association between degenerative aortic valve disease and long-term exposure to cardiovascular risk factors: results of the longitudinal population based KORA/MONICA survey. Eur Heart J. 2009;30:2044–53.
38. Dahl CF, Allen MR, Urie PM. Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals. BMC Med. 2008;6: 34-42
39. Redfield MM, Nicholson WJ, Edwards WD. Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations. Ann Intern Med. 1992;117:50–2.
40. Van Camp G, Flamez A, Cosyns . Treatment of Parkinson’s disease with pergolide and relation to restrictive valvular heart disease. Lancet. 2004;363:1179–83.